Carcinoembryonic Antigen/CEA Mouse mAb
CEA is synthesised during development in the fetal gut, and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Antibodies to CEA are useful in identifying the origin of various metastatic adenocarcinomas and in distinguishing pulmonary adenocarcinomas (60 to 70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+).
Product Specifications
Background
Product Name Alternative
Carcinoembryonic antigen, CD66e, CEACAM5, Meconium antigen 100
UniProt
P06731
Swiss Prot
P06731
Reactivity
Human, Rat, Mouse
Immunogen
Synthetic Peptide
Clonality
Monoclonal
Source
Mouse
Applications
IHC
Concentration
1mg/mL
Dilution
IHC 1:200
Buffer
PBS with 0.02% sodium azide and 50% glycerol pH 7.4. Store at -20°C. Avoid repeated freeze-thaw cycles.
Molecular Weight
113kDa
Storage Conditions
PBS with 0.02% sodium azide and 50% glycerol pH 7.4. Store at -20°C. Avoid repeated freeze-thaw cycles.
Observed Molecular Weight
113kDa
Fragment
IgG1
Other Product Names
Carcinoembryonic antigen, CD66e, CEACAM5, Meconium antigen 100
Gene ID (Human)
1048
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Danio rerio Putative deoxyribonuclease TATDN1 (tatdn1)
Recombinant Danio rerio Putative deoxyribonuclease TATDN1 (tatdn1)
Recombinant Danio rerio Putative deoxyribonuclease TATDN1 (tatdn1)
Recombinant Danio rerio Putative deoxyribonuclease TATDN1 (tatdn1)